Is Cytokinetics, Incorporated (CYTK) a Buy, Sell, or Hold?
Cytokinetics, Incorporated
NASDAQ:CYTK
$81.93 USD
-$0.31 (-0.38%)
- Volume
- 1.44M
- Average Volume
- 2.62M
- Market Capitalization
- $10.19B
- P/E Ratio
- -12.00
- Dividend Yield
- 0.00%
- Price Target
- $108.00
- Year High
- $88.31
- Year Low
- $32.89
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $4.21
CCURRENT INSTITUTIONAL OWNERSHIP PERCENTAGE
0.81%
Investors Holding
20
change: -472 | last: 492
Increased Positions
12
change: -249 | last: 261
Reduced Positions
4
change: -134 | last: 138
New Positions
3
change: -77 | last: 80
Sold Positions
433
change: 366 | last: 67
Total Calls
-
Total Puts
-
Put-Call Ratio
0.00
change: -39.6756 | last: 0.3968
Total Invested
85.27M
CYTK Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $63.54 | 120.02M | $7.63B | $122.52M | $1.28B | $8.79B |
| 2024-12-31 | $47.04 | 111.98M | $5.27B | $94.86M | $788.68M | $5.96B |
| 2023-12-31 | $83.49 | 96.52M | $8.06B | $113.02M | $755.77M | $8.7B |
| 2022-12-31 | $45.82 | 89.82M | $4.12B | $65.58M | $750.3M | $4.8B |
| 2021-12-31 | $45.58 | 76.89M | $3.5B | $112.67M | $269.93M | $3.66B |
| 2020-12-31 | $20.78 | 64.52M | $1.34B | $82.98M | $138.94M | $1.4B |
| 2019-12-31 | $10.61 | 57.58M | $610.87M | $36.43M | $136.07M | $710.51M |
| 2018-12-31 | $6.32 | 54.42M | $343.93M | $42.26M | $42.41M | $344.09M |
| 2017-12-31 | $8.15 | 49.4M | $402.64M | $125.21M | $31.78M | $309.21M |
| 2016-12-31 | $12.15 | 39.94M | $485.31M | $66.87M | $27.38M | $445.81M |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-03-31 | $65.91 | 123.27M | $8.12B | $129.84M | $1.29B | $9.28B |
| 2025-12-31 | $63.54 | 122.02M | $7.75B | $122.52M | $1.28B | $8.91B |
| 2025-09-30 | $54.96 | 119.98M | $6.59B | $225.47M | $1.2B | $7.57B |
| 2025-06-30 | $33.04 | 119.46M | $3.95B | $74.94M | $858.06M | $4.73B |
| 2025-03-31 | $40.19 | 118.5M | $4.76B | $73.68M | $791.06M | $5.48B |
| 2024-12-31 | $47.04 | 118.08M | $5.55B | $94.86M | $788.68M | $6.25B |
| 2024-09-30 | $52.80 | 117.68M | $6.21B | $46.89M | $789.63M | $6.96B |
| 2024-06-30 | $54.70 | 109.24M | $5.98B | $190.52M | $790.18M | $6.58B |
| 2024-03-31 | $73.02 | 101.92M | $7.44B | $119.98M | $754.92M | $8.08B |
| 2023-12-31 | $83.49 | 99.07M | $8.27B | $113.4M | $755.77M | $8.91B |
| 2023-09-30 | $29.46 | 96.07M | $2.83B | $99.69M | $748.47M | $3.48B |
| 2023-06-30 | $32.62 | 95.76M | $3.12B | $68.64M | $749.31M | $3.8B |